DK0772620T3 - Anti-messenger-oligonucleotider og urokinase-recepter-reversion af den invasive fænotype af transformerede humane fibroblas - Google Patents

Anti-messenger-oligonucleotider og urokinase-recepter-reversion af den invasive fænotype af transformerede humane fibroblas

Info

Publication number
DK0772620T3
DK0772620T3 DK95926907T DK95926907T DK0772620T3 DK 0772620 T3 DK0772620 T3 DK 0772620T3 DK 95926907 T DK95926907 T DK 95926907T DK 95926907 T DK95926907 T DK 95926907T DK 0772620 T3 DK0772620 T3 DK 0772620T3
Authority
DK
Denmark
Prior art keywords
pct
oligonucleotides
urokinase
messenger
prescription
Prior art date
Application number
DK95926907T
Other languages
English (en)
Inventor
Sergio Capaccioli
Rosso Mario Del
Gabriella Fibbi
Alessandro Quattrone
Original Assignee
Consiglio Nazionale Ricerche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consiglio Nazionale Ricerche filed Critical Consiglio Nazionale Ricerche
Application granted granted Critical
Publication of DK0772620T3 publication Critical patent/DK0772620T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
DK95926907T 1994-07-22 1995-07-17 Anti-messenger-oligonucleotider og urokinase-recepter-reversion af den invasive fænotype af transformerede humane fibroblas DK0772620T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI941560A IT1271684B (it) 1994-07-22 1994-07-22 Oligonucleotidi antisenso complementari all'rna messaggero del recettore umano della urochinasi
PCT/EP1995/002793 WO1996003414A1 (en) 1994-07-22 1995-07-17 Antimessenger oligonucleotides and urokinase receptor reversion of the invasive phenotype of transformed human fibroblasts by antimessenger oligonucleotide inhibition of urokinase receptor gene expression

Publications (1)

Publication Number Publication Date
DK0772620T3 true DK0772620T3 (da) 2000-03-27

Family

ID=11369344

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95926907T DK0772620T3 (da) 1994-07-22 1995-07-17 Anti-messenger-oligonucleotider og urokinase-recepter-reversion af den invasive fænotype af transformerede humane fibroblas

Country Status (11)

Country Link
US (1) US5872106A (da)
EP (1) EP0772620B1 (da)
JP (1) JP3687919B2 (da)
AT (1) ATE185144T1 (da)
AU (1) AU3112395A (da)
DE (1) DE69512522T2 (da)
DK (1) DK0772620T3 (da)
ES (1) ES2136868T3 (da)
GR (1) GR3031985T3 (da)
IT (1) IT1271684B (da)
WO (1) WO1996003414A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994309A (en) 1997-07-25 1999-11-30 Angstrom Pharmaceuticals, Inc. Anti-invasive and anti-angiogenic compositions and methods
JP4688294B2 (ja) * 1998-12-30 2011-05-25 オリゴス・イーティーシー・インコーポレイテッド 酸安定性骨格で修飾された末端がブロックされた核酸及びその治療的使用
US20050048045A1 (en) * 2003-07-02 2005-03-03 Board Of Regents, The University Of Texas System Regulation of urokinase receptor expression by phosphoglycerate kinase
WO2017043490A1 (ja) * 2015-09-07 2017-03-16 協和発酵バイオ株式会社 自然免疫誘導効果が増強した二重鎖リボ核酸

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69033653T2 (de) * 1989-04-07 2001-06-07 Cancerforskningsfonden Af 1989 Plasminogen-aktivator-rezeptor vom urokinasetyp

Also Published As

Publication number Publication date
AU3112395A (en) 1996-02-22
ITMI941560A0 (it) 1994-07-22
DE69512522D1 (de) 1999-11-04
DE69512522T2 (de) 2000-01-13
JP3687919B2 (ja) 2005-08-24
JPH10502823A (ja) 1998-03-17
ATE185144T1 (de) 1999-10-15
EP0772620B1 (en) 1999-09-29
GR3031985T3 (en) 2000-03-31
ES2136868T3 (es) 1999-12-01
EP0772620A1 (en) 1997-05-14
ITMI941560A1 (it) 1996-01-22
US5872106A (en) 1999-02-16
WO1996003414A1 (en) 1996-02-08
IT1271684B (it) 1997-06-04

Similar Documents

Publication Publication Date Title
NO952229D0 (no) Anvendelse av karbamazepin og okskarbazepin ved behandling av neurologiske lesjoner relatert til traumatiske skader
DE69835688D1 (de) Substituierte anilide
DK0683780T3 (da) Imidazopyridiner og deres anvendelse til behandling af mave-tarm-sygdomme
CY2495B1 (en) Sulfonamides.
DE69400435T2 (de) Verwendung von carbamazepine und oxcarbazepine zur behandlung von parkinson und den parkinson-syndromen
DK0760661T3 (da) Farmaceutiske sammensætninger omfattende en opiat-antagonist og calciumsalte, deres anvendelse til behandling af endorfin-m
DK0804437T3 (da) [a]-Annelerede pyrrolderivater og deres anvendelse i farmacien
PL333429A1 (en) Benzonaphtyridines useful in particular in treating bronchial diseases
BG106118A (en) Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit
ATE232094T1 (de) Verwendung eines 5ht2 rezeptor-antagonisten zur behandlung von schlafapnoe
DK0772620T3 (da) Anti-messenger-oligonucleotider og urokinase-recepter-reversion af den invasive fænotype af transformerede humane fibroblas
AU5818394A (en) Use of prodelphinidines for treating arthrosis
DK0775143T3 (da) 3-substituerede 3H-2,3-benzodiazepinderivater, deres fremstilling og anvendelse som lægdemidler
NO983103L (no) Nye monofunksjonelle EDTA-, DTPA- og TTHA-derivater og deres anvendelse i medisinsk diagnostikk og terapi
ATE200624T1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
TR199500984A2 (tr) Selegilin'in epileptik hastaliklarin tedavisinde kullanimi.
YU30602A (sh) Primena 2-amino-3,4-dihidro-hinazolina za proizvodnju leka za lečenje ili profilaksu bolesti koje su prouzrokovane ishemičnim stanjima
DK0691846T3 (da) Imidazoquinoxalinoner til behandling af sygdomme i centralnervesystemet
FI962301A0 (fi) Substituoidut aminoalkyyliaminopyridiinit
FR2700116B1 (fr) Application d'anticonvulsivants comme radioprotecteurs.
ZA983211B (en) Use of mizolastine for preparing medication for the treatment of inflammation
BR9915641A (pt) Benzil lactobionamidas como inibidores de proliferação de células de músculo liso